The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
The Oncology Institute (TOI), a leading value-based oncology group in the United States, has scheduled its fourth quarter and full year 2024 financial results announcement for March 25, 2025, after market close.
A conference call will follow at 5:00 p.m. Eastern Time on the same day. Investors can join via phone (1-877-407-0789 for domestic, 1-201-689-8562 for international) or through a simultaneous webcast on the company's Investor Relations website. A replay will be available until April 1, 2025, accessible by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) with passcode 13750791.
L'Istituto di Oncologia (TOI), un gruppo oncologico leader basato sul valore negli Stati Uniti, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 25 marzo 2025, dopo la chiusura del mercato.
Una conferenza telefonica seguirà alle 17:00 ora orientale dello stesso giorno. Gli investitori possono partecipare tramite telefono (1-877-407-0789 per chiamate nazionali, 1-201-689-8562 per chiamate internazionali) o attraverso una webconferenza simultanea sul sito web delle Relazioni con gli Investitori dell'azienda. Una registrazione sarà disponibile fino al 1° aprile 2025, accessibile componendo il numero 1-844-512-2921 (nazionale) o 1-412-317-6671 (internazionale) con il codice di accesso 13750791.
El Instituto de Oncología (TOI), un grupo oncológico líder basado en el valor en los Estados Unidos, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el 25 de marzo de 2025, después del cierre del mercado.
Una llamada de conferencia seguirá a las 5:00 p.m. hora del Este del mismo día. Los inversores pueden unirse por teléfono (1-877-407-0789 para nacionales, 1-201-689-8562 para internacionales) o a través de una transmisión web simultánea en el sitio web de Relaciones con Inversores de la empresa. Una repetición estará disponible hasta el 1 de abril de 2025, accesible marcando 1-844-512-2921 (nacional) o 1-412-317-6671 (internacional) con el código de acceso 13750791.
온콜로지 연구소 (TOI)는 미국의 가치 기반 종양학 그룹으로, 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 3월 25일 시장 마감 후로 예정하고 있습니다.
같은 날 동부 표준시 오후 5시에 컨퍼런스 콜이 이어질 예정입니다. 투자자들은 전화(국내 1-877-407-0789, 국제 1-201-689-8562)로 참여하거나 회사의 투자자 관계 웹사이트에서 동시 웹캐스트를 통해 참여할 수 있습니다. 녹음은 2025년 4월 1일까지 이용 가능하며, 1-844-512-2921(국내) 또는 1-412-317-6671(국제)로 전화하고 비밀번호 13750791을 입력하여 접근할 수 있습니다.
L'Institut d'Oncologie (TOI), un groupe oncologique basé sur la valeur aux États-Unis, a programmé l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le 25 mars 2025, après la fermeture du marché.
Une conférence téléphonique suivra à 17h00 heure de l'Est le même jour. Les investisseurs peuvent participer par téléphone (1-877-407-0789 pour les appels nationaux, 1-201-689-8562 pour les internationaux) ou via un webinaire simultané sur le site Web des Relations Investisseurs de l'entreprise. Un enregistrement sera disponible jusqu'au 1er avril 2025, accessible en composant le 1-844-512-2921 (national) ou le 1-412-317-6671 (international) avec le code d'accès 13750791.
Das Onkologie Institut (TOI), eine führende wertbasierte Onkologiegruppe in den Vereinigten Staaten, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf den 25. März 2025 nach Marktschluss angesetzt.
Am selben Tag folgt um 17:00 Uhr Eastern Time eine Telefonkonferenz. Investoren können sich telefonisch (1-877-407-0789 für nationale Anrufe, 1-201-689-8562 für internationale Anrufe) oder über ein gleichzeitiges Webcast auf der Investor Relations-Website des Unternehmens einwählen. Eine Wiederholung wird bis zum 1. April 2025 verfügbar sein, erreichbar unter 1-844-512-2921 (national) oder 1-412-317-6671 (international) mit dem Zugangscode 13750791.
- None.
- None.
CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13750791. The replay will be available until Tuesday, April 1, 2025.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
When will TOI release its Q4 and full year 2024 earnings?
How can investors access TOI's Q4 2024 earnings conference call?
Until when will TOI's Q4 2024 earnings call replay be available?
What is the replay passcode for TOI's Q4 2024 earnings call?
